Taytulla birth control sample packs recalled over placebo pills

Taytulla birth control sample packs recalled over placebo pills

Allergan is recalling nearly 170,000 sample packs of birth control pills because placebo and active capsules were packaged out of order, heightening the risk of unwanted pregnancy.

Allergan on Wednesday issued a voluntary recall of one lot of its Taytulla softgel capsules.

According to the FDA, some packages of the oral contraceptive capsules, Taytulla, may have four placebo capsules placed out of order.

Check your birth control, it might be under recall. The capsules were placed where the active pills should have been; if taken out of order, the user could experience an unintended pregnancy if other forms of contraception are not used. The brown placebo pills should be the last four of the pack.

Motorola working on a bezel-less Android One phone
Android Headlines has the goods on a handset dubbed the Motorola One Power , which features the Android One branding on the rear. The new phone is called the Motorola One Power and it will be an Android One device, according to Android Headlines .

The specific problem is that the the capsules marked for the first four days of use are non-hormonal placebo capsules instead of active capsules.

Allergan said it was notifying consumers by letter of the potential trouble. The packs affected by the recall belong to Lot# 5620706, Expiration May-2019 of Taytulla (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack.

The side-by-side photo shows incorrectly and correctly packaged Taytulla birth control pills. They've been issued since August 27, 2017. In January the company cut 1,400 jobs, and then later received bad publicity when a proposed deal with a Native American tribe was unsuccessful.

Related Articles